Compare CDT & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDT | NXTS |
|---|---|---|
| Founded | 2019 | 2009 |
| Country | United States | Israel |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1M | 2.5M |
| IPO Year | N/A | N/A |
| Metric | CDT | NXTS |
|---|---|---|
| Price | $2.46 | $4.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.2K | 32.1K |
| Earning Date | 04-15-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $0.55 |
| 52 Week High | $11.00 | $5.39 |
| Indicator | CDT | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 75.58 |
| Support Level | $0.66 | $0.66 |
| Resistance Level | $2.48 | $5.31 |
| Average True Range (ATR) | 0.69 | 0.49 |
| MACD | -0.34 | 0.05 |
| Stochastic Oscillator | 2.08 | 59.94 |
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.